About fitvia
fitvia is a Consumer company based in Wiesbaden (Germany) founded in 2015, and was acquired by Dermapharm in June 2019. Nutritional products are provided as a private label brand. Its focus areas include Food and Agriculture, Food & Beverage Products, Beverages and Coffees & Teas. Its competitors include Holy, TEATOX and P & T; 1 of its 3 listed competitors has raised funding.
Company details
Fitvia was established in 2015 in Wiesbaden, Germany, as a private label brand within the nutritional products sector. Herbal teas, meal supplements including bars and capsules, and accessories such as infusers and bottles are included in the product catalog. Natural ingredients are utilized in the manufacturing of these items, with operations focused on the European market.
- Headquarters Wiesbaden, Germany
- Stage Acquired
- SectorsConsumer
- Emailβ’β’β’β’β’β’β’β’
- Phoneβ’β’β’β’ β’β’β’β’
- Website fitvia.de
- Social X Facebook
- Acquired by Dermapharm (Jun 2019)
- Investors
- Acquired byDermapharm
(Jun 2019)
Investors in fitvia
fitvia has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Dermapharm.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Dermatological and pharmaceutical medications are developed and manufactured. | 1991 | dermapharm.de | Grunwald, Germany |
Investor details for fitvia
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of fitvia
2 dated milestones of fitvia across 4 years, from founding to its latest funding, stage changes and deals.
- Founded fitvia is founded.
- Exit Acquired by Dermapharm.
Competitors of fitvia
fitvia has 3 listed competitors in our database, 1 of them funded. They include Holy, TEATOX and P & T.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| weareholy.com | 2020 | Berlin, Germany | $13.58M | Internet first brand of Ice Tea | ||
| teatox.de | 2013 | Berlin, Germany | Tea brand | |||
| paperandtea.com | 2012 | Berlin, Germany | Specialty teas are sourced globally and offered in Berlin stores. |
Detailed competitors of fitvia
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Fitvia
Complete news archive for fitvia
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about fitvia
fitvia was founded in 2015.
fitvia is headquartered in Wiesbaden, Germany. It is registered at Wiesbaden, Hesse, Germany.
Fitvia was established in 2015 in Wiesbaden, Germany, as a private label brand within the nutritional products sector. Herbal teas, meal supplements including bars and capsules, and accessories such as infusers and bottles are included in the product catalog. Natural ingredients are utilized in the manufacturing of these items, with operations focused on the European market.
fitvia has 1 investor. Key investors include Dermapharm.
Yes. fitvia was acquired by Dermapharm in June 2019.

